Syros Pharmaceuticals Inc (SYRS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SYRS Annual Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Syros Pharmaceuticals Inc manages its resources, obligations, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2024)
(Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Sep 30 2023)
Assets
Cash & cash equivalent58.28
Marketable Securities, Current SH0.00
Cash & Short-term Investments58.00
Unbilled Receivables, Current RE0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current5.66
Total Current Assets63.93
Equipment/Property/Plant Net6.31
Long-term investments2.12
Other Assets, Noncurrent2.00
Operating Lease Right Of Use Asset11.27
Finance Lease Right Of Use Asset0.00
Total Assets85.00
Liabilities
Accounts Payable, Current AC9.65
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current18.75
Deferred Revenue, Current DE0.00
Total Current Liabilities28.39
Long-term debt41.08
Total Long-term Debt41.08
Accrued Liabilities And Employee Related Liabilities Current16.16
Operating Lease Liability Current2.58
Operating Lease Liability Noncurrent16.56
Warrant Liability Noncurrent10.08
Total Liabilities96.12
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock745.09
Retained Earnings / Accumulated Deficit-756.24
Other Equity0.00
Common Stockholder's Equity-11.12
Total Stockholder's Equity-11.12
Liabilities & Stockholder's Equity85.00
4 historic quarters locked

Sign in to unlock the full Syros Pharmaceuticals Inc balance sheet history.

About Syros Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-24-119236

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.